• | Net revenue was $80.0 million, down 3% sequentially, and down 6% year-on-year. |
• | GAAP gross margin was 52.4%, compared to 53.4% in the prior quarter, and 51.6% in the year-ago quarter. |
• | GAAP operating expenses were $45.2 million in the third quarter 2019, or 57% of net revenue, compared to $47.0 million in the prior quarter, or 57% of net revenue, and $56.4 million in the year-ago quarter, or 66% of net revenue. |
• | GAAP loss from operations was 4% of revenue, compared to loss from operations of 4% in the prior quarter, and loss from operations of 15% in the year-ago quarter. |
• | Net cash flow provided by operating activities was $21.8 million. |
• | GAAP diluted loss per share was $0.07, compared to diluted loss per share of $0.03 in the prior quarter, and diluted loss per share of $0.20 in the year-ago quarter. |
• | Non-GAAP gross margin was 63.1%. This compares to 63.9% in the prior quarter, and 62.5% in the year-ago quarter. |
• | Non-GAAP operating expenses were $30.8 million, or 38% of revenue, compared to $32.8 million or 40% of revenue in the prior quarter, and $35.6 million or 42% of revenue in the year-ago quarter. |
• | Non-GAAP income from operations was 25% of revenue, compared to 24% in the prior quarter, and 21% in the year-ago quarter. |
• | Non-GAAP diluted earnings per share was $0.23, compared to diluted earnings per share of $0.22 in the prior quarter, and diluted earnings per share of $0.19 in the year-ago quarter. |
• | Announced availability of the MxL93515 and MxL93516, new Telluride PAM4 DSPs optimized for 100G applications. |
• | Announced that Delta Electronics, Inc. has selected MaxLinear's Telluride PAM4 DSPs to develop sub-3.5W 100G single lambda DR, FR, and LR optical modules. |
• | Announced that Centera Photonics Inc. has selected MaxLinear's Telluride PAM4 DSPs and PAM 4 transimpedance amplifier for its next generation 400G-DR4 and 100G-DR1 optical modules. |
• | GAAP gross margin of approximately 52.0% to 52.5%; |
• | Non-GAAP gross margin of approximately 63.5% to 64.0%; |
• | GAAP operating expenses of approximately $44.0 million to $44.5 million; and |
• | Non-GAAP operating expenses of approximately $29.5 million to $30.5 million. |
Three Months Ended | |||||||||||
September 30, 2019 | June 30, 2019 | September 30, 2018 | |||||||||
Net revenue | $ | 80,020 | $ | 82,507 | $ | 85,010 | |||||
Cost of net revenue | 38,116 | 38,427 | 41,134 | ||||||||
Gross profit | 41,904 | 44,080 | 43,876 | ||||||||
Operating expenses: | |||||||||||
Research and development | 23,174 | 24,304 | 29,047 | ||||||||
Selling, general and administrative | 21,920 | 22,327 | 24,963 | ||||||||
Impairment losses | — | — | 2,198 | ||||||||
Restructuring charges | 144 | 416 | 236 | ||||||||
Total operating expenses | 45,238 | 47,047 | 56,444 | ||||||||
Loss from operations | (3,334 | ) | (2,967 | ) | (12,568 | ) | |||||
Interest income | 214 | 192 | 17 | ||||||||
Interest expense | (2,718 | ) | (2,853 | ) | (3,473 | ) | |||||
Other income (expense), net | 1,098 | (14 | ) | 39 | |||||||
Total interest and other expense, net | (1,406 | ) | (2,675 | ) | (3,417 | ) | |||||
Loss before income taxes | (4,740 | ) | (5,642 | ) | (15,985 | ) | |||||
Income tax benefit | (26 | ) | (3,413 | ) | (2,050 | ) | |||||
Net loss | $ | (4,714 | ) | $ | (2,229 | ) | $ | (13,935 | ) | ||
Net loss per share: | |||||||||||
Basic | $ | (0.07 | ) | $ | (0.03 | ) | $ | (0.20 | ) | ||
Diluted | $ | (0.07 | ) | $ | (0.03 | ) | $ | (0.20 | ) | ||
Shares used to compute net loss per share: | |||||||||||
Basic | 71,366 | 70,917 | 68,742 | ||||||||
Diluted | 71,366 | 70,917 | 68,742 |
Nine Months Ended | |||||||
September 30, 2019 | September 30, 2018 | ||||||
Net revenue | $ | 247,162 | $ | 297,370 | |||
Cost of net revenue | 116,101 | 134,496 | |||||
Gross profit | 131,061 | 162,874 | |||||
Operating expenses: | |||||||
Research and development | 74,877 | 90,379 | |||||
Selling, general and administrative | 67,838 | 76,581 | |||||
Impairment losses | — | 2,198 | |||||
Restructuring charges | 2,477 | 2,101 | |||||
Total operating expenses | 145,192 | 171,259 | |||||
Loss from operations | (14,131 | ) | (8,385 | ) | |||
Interest income | 553 | 54 | |||||
Interest expense | (8,546 | ) | (11,061 | ) | |||
Other income (expense), net | 429 | 193 | |||||
Total interest and other expense, net | (7,564 | ) | (10,814 | ) | |||
Loss before income taxes | (21,695 | ) | (19,199 | ) | |||
Income tax provision (benefit) | (9,901 | ) | 7,311 | ||||
Net loss | $ | (11,794 | ) | $ | (26,510 | ) | |
Net loss per share: | |||||||
Basic | $ | (0.17 | ) | $ | (0.39 | ) | |
Diluted | $ | (0.17 | ) | $ | (0.39 | ) | |
Shares used to compute net loss per share: | |||||||
Basic | 70,755 | 68,256 | |||||
Diluted | 70,755 | 68,256 |
Three Months Ended | |||||||||||
September 30, 2019 | June 30, 2019 | September 30, 2018 | |||||||||
Operating Activities | |||||||||||
Net loss | $ | (4,714 | ) | $ | (2,229 | ) | $ | (13,935 | ) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||
Amortization and depreciation | 16,419 | 16,646 | 19,767 | ||||||||
Impairment losses | — | — | 2,198 | ||||||||
Amortization of debt issuance costs and accretion of discount on debt and leases | 380 | 391 | 287 | ||||||||
Stock-based compensation | 8,359 | 8,207 | 7,940 | ||||||||
Deferred income taxes | (1,379 | ) | (4,600 | ) | 304 | ||||||
Loss on disposal of property and equipment | — | 11 | — | ||||||||
Gain on foreign currency | (183 | ) | (54 | ) | (184 | ) | |||||
Excess tax benefits on stock-based awards | (61 | ) | (2,074 | ) | (93 | ) | |||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 280 | 3,022 | 25,016 | ||||||||
Inventory | 5,108 | (122 | ) | 2,581 | |||||||
Prepaid expenses and other assets | 960 | (648 | ) | 712 | |||||||
Leased right-of-use assets | 1,309 | 981 | — | ||||||||
Accounts payable, accrued expenses and other current liabilities | (6,313 | ) | 2,961 | (10,606 | ) | ||||||
Accrued compensation | 730 | (209 | ) | 2,671 | |||||||
Accrued price protection liability | 2,291 | (7,649 | ) | (5,662 | ) | ||||||
Lease liabilities | (2,183 | ) | (2,179 | ) | — | ||||||
Other long-term liabilities | 749 | (11 | ) | (275 | ) | ||||||
Net cash provided by operating activities | 21,752 | 12,444 | 30,721 | ||||||||
Investing Activities | |||||||||||
Purchases of property and equipment | (1,219 | ) | (524 | ) | (1,609 | ) | |||||
Purchases of intangible assets | (86 | ) | — | — | |||||||
Net cash used in investing activities | (1,305 | ) | (524 | ) | (1,609 | ) | |||||
Financing Activities | |||||||||||
Repayment of debt | (20,000 | ) | (15,000 | ) | (35,000 | ) | |||||
Net proceeds from issuance of common stock | 288 | 3,305 | 91 | ||||||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (1,339 | ) | (5,408 | ) | (1,178 | ) | |||||
Net cash used in financing activities | (21,051 | ) | (17,103 | ) | (36,087 | ) | |||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 90 | 354 | 103 | ||||||||
Decrease in cash, cash equivalents and restricted cash | (514 | ) | (4,829 | ) | (6,872 | ) | |||||
Cash, cash equivalents and restricted cash at beginning of period | 67,038 | 71,867 | 75,115 | ||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 66,524 | $ | 67,038 | $ | 68,243 |
Nine Months Ended | |||||||
September 30, 2019 | September 30, 2018 | ||||||
Operating Activities | |||||||
Net loss | $ | (11,794 | ) | $ | (26,510 | ) | |
Adjustments to reconcile net loss to cash provided by operating activities: | |||||||
Amortization and depreciation | 49,928 | 59,902 | |||||
Impairment losses | — | 2,198 | |||||
Amortization of debt issuance costs and accretion of discount on debt and leases | 1,173 | 861 | |||||
Stock-based compensation | 24,313 | 23,722 | |||||
Deferred income taxes | (12,455 | ) | (3,317 | ) | |||
Loss on disposal of property and equipment | 46 | — | |||||
Impairment of leasehold improvements | 1,442 | 700 | |||||
Impairment of long-lived assets | 2,182 | — | |||||
Gain on extinguishment of lease liabilities | (2,880 | ) | — | ||||
(Gain) loss on foreign currency | 330 | (541 | ) | ||||
Excess tax benefits on stock-based awards | (3,872 | ) | (1,208 | ) | |||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | 3,160 | 7,462 | |||||
Inventory | 3,971 | 11,677 | |||||
Prepaid expenses and other assets | 916 | 3,928 | |||||
Leased right-of-use assets | 2,935 | — | |||||
Accounts payable, accrued expenses and other current liabilities | (1,431 | ) | 513 | ||||
Accrued compensation | 1,414 | 6,574 | |||||
Deferred revenue and deferred profit | — | (138 | ) | ||||
Accrued price protection liability | (2,869 | ) | (7,153 | ) | |||
Lease liabilities | (6,487 | ) | — | ||||
Other long-term liabilities | 219 | (154 | ) | ||||
Net cash provided by operating activities | 50,241 | 78,516 | |||||
Investing Activities | |||||||
Purchases of property and equipment | (3,898 | ) | (6,413 | ) | |||
Purchases of intangible assets | (86 | ) | — | ||||
Net cash used in investing activities | (3,984 | ) | (6,413 | ) | |||
Financing Activities | |||||||
Repayment of debt | (50,000 | ) | (78,000 | ) | |||
Net proceeds from issuance of common stock | 6,221 | 4,107 | |||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (11,166 | ) | (5,017 | ) | |||
Net cash used in financing activities | (54,945 | ) | (78,910 | ) | |||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,021 | 638 | |||||
Decrease in cash, cash equivalents and restricted cash | (7,667 | ) | (6,169 | ) | |||
Cash, cash equivalents and restricted cash at beginning of period | 74,191 | 74,412 | |||||
Cash, cash equivalents and restricted cash at end of period | $ | 66,524 | $ | 68,243 |
September 30, 2019 | June 30, 2019 | September 30, 2018 (1) | |||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 66,115 | $ | 66,629 | $ | 67,185 | |||||
Short-term restricted cash | 345 | 344 | 349 | ||||||||
Accounts receivable, net | 56,339 | 56,618 | 58,633 | ||||||||
Inventory | 37,642 | 42,875 | 41,757 | ||||||||
Prepaid expenses and other current assets | 4,679 | 6,184 | 6,329 | ||||||||
Total current assets | 165,120 | 172,650 | 174,253 | ||||||||
Long-term restricted cash | 64 | 65 | 709 | ||||||||
Property and equipment, net | 15,204 | 15,738 | 19,413 | ||||||||
Leased right-of-use assets | 18,719 | 20,624 | — | ||||||||
Intangible assets, net | 202,217 | 216,342 | 261,813 | ||||||||
Goodwill | 238,330 | 238,330 | 238,330 | ||||||||
Deferred tax assets | 64,046 | 62,667 | 42,691 | ||||||||
Other long-term assets | 3,065 | 2,744 | 4,935 | ||||||||
Total assets | $ | 706,765 | $ | 729,160 | $ | 742,144 | |||||
Liabilities and stockholders’ equity | |||||||||||
Current liabilities | $ | 63,119 | $ | 66,918 | $ | 66,464 | |||||
Long-term lease liabilities | 14,995 | 16,515 | — | ||||||||
Long-term debt | 206,622 | 226,335 | 270,470 | ||||||||
Other long-term liabilities | 8,678 | 8,016 | 12,816 | ||||||||
Stockholders’ equity | 413,351 | 411,376 | 392,394 | ||||||||
Total liabilities and stockholders’ equity | $ | 706,765 | $ | 729,160 | $ | 742,144 |
Three Months Ended | |||||||||||
September 30, 2019 | June 30, 2019 | September 30, 2018 | |||||||||
GAAP gross profit | $ | 41,904 | $ | 44,080 | $ | 43,876 | |||||
Stock-based compensation | 151 | 147 | 131 | ||||||||
Performance based equity | — | — | 53 | ||||||||
Amortization of purchased intangible assets | 8,477 | 8,478 | 8,969 | ||||||||
Depreciation of fixed asset step-up | — | — | 95 | ||||||||
Non-GAAP gross profit | 50,532 | 52,705 | 53,124 | ||||||||
GAAP R&D expenses | 23,174 | 24,304 | 29,047 | ||||||||
Stock-based compensation | (4,155 | ) | (4,222 | ) | (4,726 | ) | |||||
Performance based equity | (45 | ) | — | (1,517 | ) | ||||||
Depreciation of fixed asset step-up | — | — | (321 | ) | |||||||
Non-GAAP R&D expenses | 18,974 | 20,082 | 22,483 | ||||||||
GAAP SG&A expenses | 21,920 | 22,327 | 24,963 | ||||||||
Stock-based compensation | (4,068 | ) | (3,823 | ) | (3,070 | ) | |||||
Performance based equity | (279 | ) | — | (785 | ) | ||||||
Amortization of purchased intangible assets | (5,722 | ) | (5,792 | ) | (7,994 | ) | |||||
Depreciation of fixed asset step-up | — | — | (12 | ) | |||||||
IP litigation costs, net | (71 | ) | (13 | ) | (19 | ) | |||||
Non-GAAP SG&A expenses | 11,780 | 12,699 | 13,083 | ||||||||
GAAP impairment losses | — | — | 2,198 | ||||||||
Impairment losses | — | — | (2,198 | ) | |||||||
Non-GAAP impairment losses | — | — | — | ||||||||
GAAP restructuring expenses | 144 | 416 | 236 | ||||||||
Restructuring charges | (144 | ) | (416 | ) | (236 | ) | |||||
Non-GAAP restructuring expenses | — | — | — | ||||||||
GAAP loss from operations | (3,334 | ) | (2,967 | ) | (12,568 | ) | |||||
Total non-GAAP adjustments | 23,112 | 22,891 | 30,126 | ||||||||
Non-GAAP income from operations | 19,778 | 19,924 | 17,558 | ||||||||
GAAP and non-GAAP interest and other income (expense), net | (1,406 | ) | (2,675 | ) | (3,417 | ) | |||||
Non-recurring gain on reversal of liability | (1,006 | ) | — | — | |||||||
Non-GAAP interest and other income (expense), net | (2,412 | ) | (2,675 | ) | (3,417 | ) | |||||
GAAP loss before income taxes | (4,740 | ) | (5,642 | ) | (15,985 | ) | |||||
Total non-GAAP adjustments | 22,106 | 22,891 | 30,126 | ||||||||
Non-GAAP income before income taxes | 17,366 | 17,249 | 14,141 | ||||||||
GAAP income tax benefit | (26 | ) | (3,413 | ) | (2,050 | ) | |||||
Adjustment for non-cash tax benefits/expenses and effects of the Tax Act | 894 | 4,621 | 3,040 | ||||||||
Non-GAAP income tax provision | 868 | 1,208 | 990 | ||||||||
GAAP net loss | (4,714 | ) | (2,229 | ) | (13,935 | ) | |||||
Total non-GAAP adjustments before income taxes | 22,106 | 22,891 | 30,126 | ||||||||
Less: total tax adjustments | 894 | 4,621 | 3,040 | ||||||||
Non-GAAP net income | $ | 16,498 | $ | 16,041 | $ | 13,151 | |||||
Shares used in computing non-GAAP basic net income per share | 71,366 | 70,917 | 68,742 | ||||||||
Shares used in computing non-GAAP diluted net income per share | 72,506 | 72,389 | 70,634 | ||||||||
Non-GAAP basic net income per share | $ | 0.23 | $ | 0.23 | $ | 0.19 | |||||
Non-GAAP diluted net income per share | $ | 0.23 | $ | 0.22 | $ | 0.19 |
Nine Months Ended | |||||||
September 30, 2019 | September 30, 2018 | ||||||
GAAP gross profit | $ | 131,061 | $ | 162,874 | |||
Stock-based compensation | 428 | 357 | |||||
Performance based equity | 73 | 178 | |||||
Amortization of purchased intangible assets | 25,379 | 26,906 | |||||
Depreciation of fixed asset step-up | — | 303 | |||||
Non-GAAP gross profit | 156,941 | 190,618 | |||||
GAAP R&D expenses | 74,877 | 90,379 | |||||
Stock-based compensation | (12,590 | ) | (13,554 | ) | |||
Performance based equity | (970 | ) | (3,954 | ) | |||
Depreciation of fixed asset step-up | (6 | ) | (974 | ) | |||
Non-GAAP R&D expenses | 61,311 | 71,897 | |||||
GAAP SG&A expenses | 67,838 | 76,581 | |||||
Stock-based compensation | (11,295 | ) | (9,798 | ) | |||
Performance based equity | (1,218 | ) | (2,564 | ) | |||
Amortization of purchased intangible assets | (17,312 | ) | (23,982 | ) | |||
Depreciation of fixed asset step-up | — | (34 | ) | ||||
IP litigation costs, net | (84 | ) | (80 | ) | |||
Non-GAAP SG&A expenses | 37,929 | 40,123 | |||||
GAAP impairment losses | — | 2,198 | |||||
Impairment losses | — | (2,198 | ) | ||||
Non-GAAP impairment losses | — | — | |||||
GAAP restructuring expenses | 2,477 | 2,101 | |||||
Restructuring charges | (2,477 | ) | (2,101 | ) | |||
Non-GAAP restructuring expenses | — | — | |||||
GAAP loss from operations | (14,131 | ) | (8,385 | ) | |||
Total non-GAAP adjustments | 71,832 | 86,983 | |||||
Non-GAAP income from operations | 57,701 | 78,598 | |||||
GAAP and non-GAAP interest and other income (expense), net | (7,564 | ) | (10,814 | ) | |||
Non-recurring gain on reversal of liability | (1,006 | ) | — | ||||
Non-GAAP interest and other income (expense), net | (8,570 | ) | (10,814 | ) | |||
GAAP loss before income taxes | (21,695 | ) | (19,199 | ) | |||
Total non-GAAP adjustments | 70,826 | 86,983 | |||||
Non-GAAP income before income taxes | 49,131 | 67,784 | |||||
GAAP income tax provision (benefit) | (9,901 | ) | 7,311 | ||||
Adjustment for non-cash tax benefits/expenses and effects of the Tax Act | 12,993 | (2,566 | ) | ||||
Non-GAAP income tax provision | 3,092 | 4,745 | |||||
GAAP net loss | (11,794 | ) | (26,510 | ) | |||
Total non-GAAP adjustments before income taxes | 70,826 | 86,983 | |||||
Less: total tax adjustments | 12,993 | (2,566 | ) | ||||
Non-GAAP net income | $ | 46,039 | $ | 63,039 | |||
Shares used in computing non-GAAP basic net income per share | 70,755 | 68,256 | |||||
Shares used in computing non-GAAP diluted net income per share | 72,270 | 70,521 | |||||
Non-GAAP basic net income per share | $ | 0.65 | $ | 0.92 | |||
Non-GAAP diluted net income per share | $ | 0.64 | $ | 0.89 |
Three Months Ended | ||||||||
September 30, 2019 | June 30, 2019 | September 30, 2018 | ||||||
GAAP gross profit | 52.4 | % | 53.4 | % | 51.6 | % | ||
Stock-based compensation | 0.2 | % | 0.2 | % | 0.2 | % | ||
Performance based equity | — | % | — | % | 0.1 | % | ||
Amortization of purchased intangible assets | 10.6 | % | 10.3 | % | 10.6 | % | ||
Depreciation of fixed asset step-up | — | % | — | % | 0.1 | % | ||
Non-GAAP gross profit | 63.1 | % | 63.9 | % | 62.5 | % | ||
GAAP R&D expenses | 29.0 | % | 29.5 | % | 34.2 | % | ||
Stock-based compensation | (5.2 | )% | (5.1 | )% | (5.6 | )% | ||
Performance based equity | (0.1 | )% | — | % | (1.8 | )% | ||
Depreciation of fixed asset step-up | — | % | — | % | (0.5 | )% | ||
Non-GAAP R&D expenses | 23.7 | % | 24.3 | % | 26.4 | % | ||
GAAP SG&A expenses | 27.4 | % | 27.1 | % | 29.4 | % | ||
Stock-based compensation | (5.1 | )% | (4.6 | )% | (3.6 | )% | ||
Performance based equity | (0.3 | )% | — | % | (0.9 | )% | ||
Amortization of purchased intangible assets | (7.2 | )% | (7.0 | )% | (9.4 | )% | ||
Depreciation of fixed asset step-up | — | % | — | % | — | % | ||
IP litigation costs, net | (0.1 | )% | — | % | — | % | ||
Non-GAAP SG&A expenses | 14.7 | % | 15.4 | % | 15.4 | % | ||
GAAP impairment losses | — | % | — | % | 2.6 | % | ||
Impairment losses | — | % | — | % | (2.6 | )% | ||
Non-GAAP impairment losses | — | % | — | % | — | % | ||
GAAP restructuring expenses | 0.2 | % | 0.5 | % | 0.3 | % | ||
Restructuring charges | (0.2 | )% | (0.5 | )% | (0.3 | )% | ||
Non-GAAP restructuring expenses | — | % | — | % | — | % | ||
GAAP loss from operations | (4.2 | )% | (3.6 | )% | (14.8 | )% | ||
Total non-GAAP adjustments | 28.9 | % | 27.7 | % | 35.4 | % | ||
Non-GAAP income from operations | 24.7 | % | 24.1 | % | 20.7 | % | ||
GAAP interest and other income (expense), net | (1.8 | )% | (3.2 | )% | (4.0 | )% | ||
Nonrecurring gain on reversal of liability | (1.3 | )% | — | % | — | % | ||
Non-GAAP interest and other income (expense), net | (3.0 | )% | (3.2 | )% | (4.0 | )% | ||
GAAP loss before income taxes | (5.9 | )% | (6.8 | )% | (18.8 | )% | ||
Total non-GAAP adjustments before income taxes | 27.6 | % | 27.7 | % | 35.4 | % | ||
Non-GAAP income before income taxes | 21.7 | % | 20.9 | % | 16.6 | % | ||
GAAP income tax benefit | — | % | (4.1 | )% | (2.4 | )% | ||
Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act | 1.1 | % | 5.6 | % | 3.6 | % | ||
Non-GAAP income tax provision | 1.1 | % | 1.5 | % | 1.2 | % | ||
GAAP net loss | (5.9 | )% | (2.7 | )% | (16.4 | )% | ||
Total non-GAAP adjustments before income taxes | 27.6 | % | 27.7 | % | 35.4 | % | ||
Less: total tax adjustments | 1.1 | % | 5.6 | % | 3.6 | % | ||
Non-GAAP net income | 20.6 | % | 19.4 | % | 15.5 | % |
Nine Months Ended | |||||
September 30, 2019 | September 30, 2018 | ||||
GAAP gross profit | 53.0 | % | 54.8 | % | |
Stock-based compensation | 0.2 | % | 0.1 | % | |
Performance based equity | — | % | 0.1 | % | |
Amortization of purchased intangible assets | 10.3 | % | 9.0 | % | |
Depreciation of fixed asset step-up | — | % | 0.1 | % | |
Non-GAAP gross profit | 63.5 | % | 64.1 | % | |
GAAP R&D expenses | 30.3 | % | 30.4 | % | |
Stock-based compensation | (5.1 | )% | (4.6 | )% | |
Performance based equity | (0.4 | )% | (1.3 | )% | |
Depreciation of fixed asset step-up | — | % | (0.3 | )% | |
Non-GAAP R&D expenses | 24.8 | % | 24.2 | % | |
GAAP SG&A expenses | 27.4 | % | 25.8 | % | |
Stock-based compensation | (4.6 | )% | (3.3 | )% | |
Performance based equity | (0.5 | )% | (0.9 | )% | |
Amortization of purchased intangible assets | (7.0 | )% | (8.1 | )% | |
Depreciation of fixed asset step-up | — | % | — | % | |
IP litigation costs, net | — | % | — | % | |
Non-GAAP SG&A expenses | 15.3 | % | 13.5 | % | |
GAAP impairment losses | — | % | 0.7 | % | |
Impairment losses | — | % | (0.7 | )% | |
Non-GAAP impairment losses | — | % | — | % | |
GAAP restructuring expenses | 1.0 | % | 0.7 | % | |
Restructuring charges | (1.0 | )% | (0.7 | )% | |
Non-GAAP restructuring expenses | — | % | — | % | |
GAAP loss from operations | (5.7 | )% | (2.8 | )% | |
Total non-GAAP adjustments | 29.1 | % | 29.3 | % | |
Non-GAAP income from operations | 23.3 | % | 26.4 | % | |
GAAP interest and other income (expense), net | (3.1 | )% | (3.6 | )% | |
Nonrecurring gain on reversal of liability | (0.4 | )% | — | % | |
Non-GAAP interest and other income (expense), net | (3.5 | )% | (3.6 | )% | |
GAAP loss before income taxes | (8.8 | )% | (6.5 | )% | |
Total non-GAAP adjustments before income taxes | 28.7 | % | 29.3 | % | |
Non-GAAP income before income taxes | 19.9 | % | 22.8 | % | |
GAAP income tax provision (benefit) | (4.0 | )% | 2.5 | % | |
Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act | 5.3 | % | (0.9 | )% | |
Non-GAAP income tax provision | 1.3 | % | 1.6 | % | |
GAAP net loss | (4.8 | )% | (8.9 | )% | |
Total non-GAAP adjustments before income taxes | 28.7 | % | 29.3 | % | |
Less: total tax adjustments | 5.3 | % | (0.9 | )% | |
Non-GAAP net income | 18.6 | % | 21.2 | % |